|
注册号: Registration number: |
ChiCTR2100052314 |
|
最近更新日期: Date of Last Refreshed on: |
2022-07-01 10:57:37 |
|
注册时间: Date of Registration: |
2021-10-24 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
曲安奈德注射液灌洗腮腺治疗对干燥综合征腮腺唾液分泌的影响 |
|
Public title: |
Effect of triamcinolone acetonide for parotid gland lavage on the salivary secretion of patients with Sjogren's syndrome |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
曲安奈德注射液经腮腺导管灌洗腮腺治疗对干燥综合征腮腺唾液分泌的影响 |
|
Scientific title: |
Effect of triamcinolone acetonide irrigation through parotid duct for parotid gland salivary secretion of patients with Sjogren's syndrome |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
杜洪明 |
研究负责人: |
杜洪明 |
|
Applicant: |
Du Hongming |
Study leader: |
Du Hongming |
|
申请注册联系人电话: Applicant telephone: |
+86 17721508525 |
研究负责人电话:
Study leader's |
+86 17721508525 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
dhm_010@sina.com |
研究负责人电子邮件: Study leader's E-mail: |
dhm_010@sina.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
江苏省南京市汉中路136号 |
研究负责人通讯地址: |
江苏省南京市汉中路136号 |
|
Applicant address: |
136 Hanzhong Road, Nanjing, Jiangsu |
Study leader's address: |
136 Hanzhong Road, Nanjing, Jiangsu |
|
申请注册联系人邮政编码: Applicant postcode: |
210029 |
研究负责人邮政编码: Study leader's postcode: |
210029 |
|
申请人所在单位: |
南京医科大学附属口腔医院 |
||
|
Applicant's institution: |
Affiliated Stomatological Hospital of Nanjing Medical University |
||
|
研究负责人所在单位: |
南京医科大学附属口腔医院 |
||
|
Affiliation of the Leader: |
Affiliated Stomatological Hospital of Nanjing Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
PJ2021-096-001 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
南京医科大学附属口腔医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Affiliated Hospital of Stomatology, Nanjing Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2021-10-01 00:00:00 | ||
|
伦理委员会联系人: |
王娟 |
||
|
Contact Name of the ethic committee: |
Wang Juan |
||
|
伦理委员会联系地址: |
江苏省南京市汉中路136号 |
||
|
Contact Address of the ethic committee: |
136 Hanzhong Road, Nanjing, Jiangsu |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
南京医科大学附属口腔医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Affiliated Stomatological Hospital of Nanjing Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
江苏省南京市汉中路136号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
136 Hanzhong Road, Nanjing, Jiangsu |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
国家自然科学基金 (No. 81600908 and 81701491); 江苏省自然科学基金 (No. BK2018040793 and BK20170152)。 |
||||||||||||||||||||||
|
Source(s) of funding: |
the National Natural Science Foundation of China (No. 81600908 and 81701491), the Nature Science Foundation of Jiangsu Province (No. BK2018040793 and BK20170152) |
||||||||||||||||||||||
|
研究疾病: |
干燥综合征 |
||||||||||||||||||||||
|
Target disease: |
Sjogren syndrome |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
上市后药物 | ||||||||||||||||||||||
|
Study phase: |
4 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
干燥综合征是一种主要累及外分泌腺的慢性炎症性自身免疫性疾病,也称为累及外分泌腺的自身免疫性性疾病。腮腺是分泌量最大的唾液腺,慢性炎症对腮腺的损害更为严重,导致唾液分泌减少。曲安奈德作为一种长期的糖皮质激素,能有效抑制慢性炎症反应。提示经腮腺导管注入曲安奈德可抑制干燥综合征引起的慢性炎症反应,保护腮腺功能,促进唾液分泌。因此,我们设计了这项前瞻性随机对照研究,以确定用于腮腺灌洗的曲安普洛酮对干燥综合征患者唾液分泌的影响。 |
||||||||||||||||||||||
|
Objectives of Study: |
Sjogren's syndrome is a chronic inflammatory autoimmune disease mainly involving exocrine glands, also known as an autoimmune disease that affects exocrine tissues. The parotid gland, as the salivary gland with the largest amount of secretion, is more seriously damaged by chronic inflammation, resulting in decreased salivary secretion. As a long-term glucocorticoid, triamcinolone acetonide can effectively inhibit chronic inflammatory responses. It is suggested that the use of triamcinolone acetonide to the parotid gland through the parotid duct can inhibit the chronic inflammatory response caused by Sjogren's syndrome, protecting the function of the parotid gland, and promoting salivation. Therefore, we designed this prospective randomized controlled study to determine the effect of triamcinolone acetonide for parotid gland lavage on the salivary secretion of patients with Sjogren's syndrome. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
重叠综合征、全身系统其他疾病及唾液腺急性感染性疾病的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Patients with overlap syndrome, systemic systemic diseases and salivary gland acute infectious diseases. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2021-11-01 00:00:00至 To 2022-06-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2021-11-01 00:00:00 至 To 2022-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
受试者,使用计算机随机软件,随机分入实验组和对照组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The subjects were randomly divided into experimental group and control group using computer random software. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
Not stated |
|
Blinding: |
Not stated |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2023年6月31日前,临床试验公共管理平台,http://www.medresman.org/login.aspx,提供免费查阅和下载。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Before June 31, 2023, all experimental data will be uploaded to http://www.medresman.org/login.aspx for free viewing and downloading. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form, CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |